Abstract | OBJECTIVE: DESIGN: Prospective study. PATIENTS: We studied 101 women with PCOS (age 26·1 ± 6·4 years, BMI 34·5 ± 5·9 kg/m(2) ) and 29 BMI-matched women with normal ovulating cycles. All women were instructed to follow a low-calorie diet to exercise and were treated with orlistat 120 mg tid for 6 months. MEASUREMENTS: Metabolic and endocrine characteristics of PCOS, blood pressure (BP) and lipid profile. RESULTS: A significant and comparable reduction in BMI was observed in women with PCOS and controls. Systolic and diastolic BP decreased only in women with PCOS. Serum low-density lipoprotein cholesterol levels decreased in both women with PCOS and controls; however, this reduction was greater in controls. In contrast, serum high-density lipoprotein cholesterol levels did not change in women with PCOS and decreased in controls. Serum triglyceride levels decreased significantly and to a comparable degree in the two groups. Similarly, markers of IR improved significantly and to a comparable degree in women with PCOS and controls. Serum testosterone levels and the free androgen index decreased significantly in women with PCOS and did not change in controls. CONCLUSIONS:
Orlistat combined with lifestyle changes induces substantial weight loss in women with PCOS, resulting in improvements in IR, hyperandrogenemia and cardiovascular risk factors.
|
Authors | Dimitrios Panidis, Konstantinos Tziomalos, Efstathios Papadakis, Panagiotis Chatzis, Eleni A Kandaraki, Elena A Tsourdi, Ilias Katsikis |
Journal | Clinical endocrinology
(Clin Endocrinol (Oxf))
Vol. 80
Issue 3
Pg. 432-8
(Mar 2014)
ISSN: 1365-2265 [Electronic] England |
PMID | 23909452
(Publication Type: Controlled Clinical Trial, Journal Article)
|
Copyright | © 2013 John Wiley & Sons Ltd. |
Chemical References |
- Anti-Obesity Agents
- Lactones
- Orlistat
|
Topics |
- Adult
- Anti-Obesity Agents
(therapeutic use)
- Body Mass Index
- Caloric Restriction
- Combined Modality Therapy
- Exercise
- Female
- Humans
- Lactones
(therapeutic use)
- Life Style
- Obesity
(complications, therapy)
- Orlistat
- Overweight
(complications, therapy)
- Polycystic Ovary Syndrome
(complications, epidemiology, therapy)
- Weight Loss
(drug effects)
- Weight Reduction Programs
- Young Adult
|